Get informed when a big investor buys or sells
+ Follow-1961.10
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
The latest P/E ratio for TNPH is -1961.1. That is below the sector sector average of 22.49. Investors often review this figure alongside Tian'an Pharmaceutical , Ltd.'s historical trend and sector peers before judging valuation or financial health.
Against its sector companies, TNPH currently prints -1961.1 for P/E ratio, while the sector average sits near 22.49. That is roughly 8821.0% below the sector mean. Large gaps often invite a closer look at Tian'an Pharmaceutical , Ltd.'s growth, margins, and balance sheet.
A P/E ratio of -1961.1 for Tian'an Pharmaceutical , Ltd. is not 'good' or 'bad' on its own. Compare it with the peer average (22.49) and with TNPH's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.
After noting TNPH's P/E ratio (-1961.1), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.